rs61730251
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020937.4(FANCM):c.3920A>G(p.Tyr1307Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000837 in 1,613,804 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_020937.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00430 AC: 654AN: 152188Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00123 AC: 308AN: 250856Hom.: 2 AF XY: 0.000804 AC XY: 109AN XY: 135574
GnomAD4 exome AF: 0.000478 AC: 698AN: 1461498Hom.: 7 Cov.: 32 AF XY: 0.000399 AC XY: 290AN XY: 727060
GnomAD4 genome AF: 0.00429 AC: 653AN: 152306Hom.: 5 Cov.: 32 AF XY: 0.00391 AC XY: 291AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
- -
Premature ovarian failure 15 Benign:1
- -
Fanconi anemia Benign:1
- -
not provided Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
BA1, BS2_supporting, BP4_Moderate c.3920A>G, located in exon 14 of the FANCM gene, is predicted to result in the substitution of tyrosine by cysteine at codon 1307, p.(Tyr1307Cys). The variant allele was found in 376/23606 alleles, with a filtering allele frequency of 1.4% at 99% confidence, within the African population in the gnomAD v2.1.1 database (non-cancer data set) (BA1). The SpliceAI algorithm predicts no significant impact on splicing. The REVEL meta-predictor score for this variant (0.031) suggests that it does not affect the protein function according to Pejaver 2022 thresholds (PMID: 36413997) (BP4_Moderate). To our knowledge, neither relevant clinical data nor well-established functional studies have been reported for this variant. It has been found in 5 out of 60466 breast cancer-affected cases and 3 out of 53461 controls (PMID: 33471991). This variant has been observed in homozygous state in multiple healthy individuals (BS2). This variant has been reported in the ClinVar database (4x benign) and in LOVD (2x unclassified). Based on currently available information, the variant c.3920A>G should be considered a benign variant, according to ACMG/AMP classification guidelines. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at